Point72 Asia (Singapore) Pte. Ltd. Veracyte, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 5,021 shares of VCYT stock, worth $203,752. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,021
Previous 2,685
87.0%
Holding current value
$203,752
Previous $58.2 Million
193.73%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
311Shares Held
81.6MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$314 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$204 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$200 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$172 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.9B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...